STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7
Clinical trials for STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests if weekly chemo beats standard schedule for tough cancers
Disease control OngoingThis large, Phase 3 trial aimed to find out if giving a key chemotherapy drug (paclitaxel) once a week is better than giving it once every three weeks for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer. All patients also received another standard che…
Matched conditions: STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Major cancer trial tests new drug combo for Tough-to-Treat ovarian cancer
Disease control OngoingThis large, late-stage trial is testing which combination of chemotherapy drugs works best for women with a specific type of ovarian or fallopian tube cancer (mucinous adenocarcinoma). It compares two standard drug pairs, with or without an added drug (bevacizumab) that blocks tu…
Matched conditions: STAGE IIA FALLOPIAN TUBE CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC